Correlation of normal-range FMR1 repeat length or genotypes and reproductive parameters
- 198 Downloads
This study aims to ascertain whether the length of normal-ranged CGG repeats on the FMR1 gene correlates with abnormal reproductive parameters.
We performed a retrospective, cross-sectional study of all FMR1 carrier screening performed as part of routine care at a large university-based fertility center from January 2011 to March 2014. Correlations were performed between normal-range FMR1 length and baseline serum anti-Müllerian hormone (AMH), cycle day 3 follicle stimulating hormone (FSH), ovarian volumes (OV), antral follicle counts (AFC), and incidence of diminished ovarian reserve (DOR), while controlling for the effect of age.
Six hundred three FMR1 screening results were collected. One subject was found to be a pre-mutation carrier and was excluded from the study. Baseline serum AMH, cycle day 3 FSH, OV, and AFC data were collected for the 602 subjects with normal-ranged CGG repeats. No significant difference in median age was noted amongst any of the FMR1 repeat genotypes. No significant correlation or association was found between any allele length or genotype, with any of the reproductive parameters or with incidence of DOR at any age (p > 0.05). However, subjects who were less than 35 years old with low/low genotype were significantly more likely to have below average AMH levels compared to those with normal/normal genotype (RR 3.82; 95 % CI 1.38–10.56).
This large study did not demonstrate any substantial association between normal-range FMR1 repeat lengths and reproductive parameters.
KeywordsFragile X FMR1 Diminished ovarian reserve
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflicts of interest.
Disclosure of funding
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study, formal consent is not required.
- 8.Kronquist KE, Sherman SL, Spector EB. Clinical significance of tri-nucleotide repeats in Fragile X testing: a clarification of American College of Medical Genetics guidelines. Genet Med Off J Am Coll Med Genet. 2008;10:845–7.Google Scholar
- 13.Gleicher N, Weghofer A, Lee IH, Barad DH. Association of FMR1 genotypes with in vitro fertilization (IVF) outcomes based on ethnicity/race. Agoulnik I, editor. PLoS ONE. 2011;6:e18781Google Scholar
- 15.DNA screening for the important moments in life [Internet]. Counsyl. [cited 2016 Jan 26]. Available from: https://www.counsyl.com/services/family-prep-screen/clinical-info/.
- 16.Ferraretti AP, Marca AL, Fauser BCJM, Tarlatzis B, Nargund G, Gianaroli L, et al. ESHRE consensus on the definition of “poor response” to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod. 2011;der092.Google Scholar
- 18.Practice Committee of the American Society for Reproductive Medicine. Testing and interpreting measures of ovarian reserve: a committee opinion. Fertil Steril. 2015;103:e9–17.Google Scholar
- 21.Gleicher N, Yu Y, Himaya E, Barad DH, Weghofer A, Wu Y-G, et al. Early decline in functional ovarian reserve in young women with low (CGGn < 26) FMR1 gene alleles. Transl Res. [Internet]. 2015 [cited 2015 Aug 31]; Available from: http://linkinghub.elsevier.com/retrieve/pii/S1931524415002194
- 22.Gleicher N, Weghofer A, Kim A, Barad DH. The impact in older women of ovarian FMR1 genotypes and sub-genotypes on ovarian reserve. Veitia RA, editor. PLoS One. 2012;7:e33638.Google Scholar
- 26.De Geyter C, M’Rabet N, De Geyter J, Zürcher S, Moffat R, Bösch N, et al. Similar prevalence of expanded CGG repeat lengths in the fragile X mental retardation I gene among infertile women and among women with proven fertility: a prospective study. Genet Med. 2014;16:374–8.CrossRefPubMedGoogle Scholar
- 29.Schufreider A, McQueen DB, Lee SM, Allon R, Uhler ML, Davie J, et al. Diminished ovarian reserve is not observed in infertility patients with high normal CGG repeats on the fragile X mental retardation 1 (FMR1) gene. Hum Reprod. 2015;dev220.Google Scholar
- 32.Pastore LM, Johnson J. The FMR1 gene, infertility, and reproductive decision-making: a review. Front Genet. [Internet]. 2014 [cited 2014 Sep 29];5. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4083559/.
- 34.Gleicher N, Kushnir VA, Barad DH. Prospectively assessing risk for premature ovarian senescence in young females: a new paradigm. Reprod Biol Endocrinol. [Internet]. 2015 [cited 2015 Jun 4];13. Available from: http://www.rbej.com/content/13/1/34.